Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Rosacea
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Cause == [[File:Steroid Rosacea.jpg|thumb|Topical steroid-induced rosacea ''(left)''; after steroid withdrawal and photobiomodulation therapy ''(right)'']] The exact cause of rosacea is unknown.<ref name="Tuzun2014" /> Triggers that cause episodes of flushing and blushing play a part in its development. Exposure to temperature extremes, strenuous exercise, heat from sunlight, severe [[sunburn]], stress, anxiety, cold wind, and moving to a warm or hot environment from a cold one, such as heated shops and offices during the winter, can each cause the face to become flushed.<ref name="Tuzun2014" /> Certain foods and drinks can also trigger flushing, such as alcohol, foods, and beverages containing [[caffeine]] (especially hot tea and coffee), foods high in [[histamine]]s, and [[spicy food]]s.<ref name=DelRosso2014 /> Medications and topical irritants have also been known to trigger rosacea flares. Some [[Acne vulgaris|acne]] and wrinkle treatments reported to cause rosacea include [[microdermabrasion]] and [[chemical peels]], as well as high dosages of [[isotretinoin]], [[benzoyl peroxide]], and [[tretinoin]]. [[steroid rosacea|Steroid-induced rosacea]] is caused by topical use of [[steroid]]s,<ref name="urlDermNetNZ">{{cite web |url = http://www.dermnetnz.org/acne/rosacea.html |title = Rosacea |publisher = DermNet, [[New Zealand Dermatological Society]] |access-date = 3 February 2011 |url-status = live |archive-url = https://web.archive.org/web/20101207111722/http://dermnetnz.org/acne/rosacea.html |archive-date = 7 December 2010 }}</ref> which are often prescribed for [[seborrheic dermatitis]]. Dosage should be slowly decreased and not immediately stopped to avoid a flare-up. === Cathelicidins === In 2007, [[Richard Gallo]] and colleagues noticed that patients with rosacea had high levels of [[cathelicidin]], an [[antimicrobial peptide]],<ref name="pmid17676051">{{cite journal |author1 = Kenshi Yamasaki |author2 = Anna Di Nardo |author3 = Antonella Bardan |author4 = Masamoto Murakami |author5 = Takaaki Ohtake |author6 = Alvin Coda |author7 = Robert A Dorschner |author8 = Chrystelle Bonnart |author9 = Pascal Descargues |author10 = Alain Hovnanian |author11 = Vera B Morhenn |author12 = Richard L Gallo |title = Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea |journal = [[Nature Medicine]] |volume = 13 |issue = 8 |pages = 975β80 |date = August 2007 |pmid = 17676051 |doi = 10.1038/nm1616 |s2cid = 23470611 }}</ref> and elevated levels of [[stratum corneum]] tryptic [[enzyme]]s ([[KLK5|SCTEs]]). [[Antibiotic]]s have been used in the past to treat rosacea, but they may only work because they inhibit some SCTEs.<ref name="pmid17676051" /> === Demodex folliculitis and ''Demodex'' mites === Studies of rosacea and ''[[Demodex]]'' mites have revealed that some people with rosacea have increased numbers of the mite,<ref name=DelRosso2014 /> especially those with steroid-induced rosacea. [[Demodex folliculitis]] (demodicidosis, also known as "mange" in animals) is a condition that may have a "rosacea-like" appearance.<ref name="Baima2002">{{cite journal |vauthors = Baima B, Sticherling M |title = Demodicidosis revisited |journal = Acta Dermato-Venereologica |volume = 82 |issue = 1 |pages = 3β6 |year = 2002 |pmid = 12013194 |doi = 10.1080/000155502753600795 |doi-access = free }}</ref> A 2007, [[National Rosacea Society]]-funded study demonstrated that ''[[Demodex folliculorum]]'' mites may be a cause or exacerbating factor in rosacea.<ref name=lacey>{{cite journal |vauthors = Lacey N, Delaney S, Kavanagh K, Powell FC |title = Mite-related bacterial antigens stimulate inflammatory cells in rosacea |journal = [[British Journal of Dermatology]] |volume = 157|issue = 3 |pages = 474β481 |year = 2007 |pmid = 17596156|doi = 10.1111/j.1365-2133.2007.08028.x|s2cid = 8057780 |url = http://eprints.maynoothuniversity.ie/607/1/clinical.pdf }}</ref> The researchers identified ''[[Bacillus oleronius]]'' as a distinct bacterium associated with ''Demodex'' mites. When analyzing blood samples using a peripheral blood mononuclear cell proliferation assay, they discovered that ''B. oleronius'' stimulated an immune system response in 79 percent of 22 patients with subtype 2 (papulopustular) rosacea, compared with only 29% of 17 subjects without the disorder. They concluded, "The immune response results in inflammation, as evident in the papules (bumps) and [[Cutaneous condition#Pustule|pustules]] (pimples) of subtype 2 rosacea. This suggests that the ''B. oleronius'' bacteria found in the mites could be responsible for the inflammation associated with the condition."<ref name=lacey /> === Intestinal bacteria === [[Small intestinal bacterial overgrowth]] (SIBO) was demonstrated to have a greater prevalence in rosacea patients, and treating it with locally acting antibiotics led to rosacea lesion improvement in two studies. Conversely, in rosacea patients who were SIBO-negative, antibiotic therapy had no effect.<ref>{{cite journal |author1 = Elizabeth Lazaridou |author2 = Christina Giannopoulou |author3 = Christina Fotiadou |author4 = Eustratios Vakirlis |author5 = Anastasia Trigoni |author6 = Demetris Ioannides |title = The potential role of microorganisms in the development of rosacea |journal = JDDG: Journal der Deutschen Dermatologischen Gesellschaft |date = November 2010 |pages = 21β25 |volume = 9 |issue = 1 |pmid = 21059171 |doi = 10.1111/j.1610-0387.2010.07513.x |s2cid = 23494211 |doi-access = free }}</ref> The effectiveness of treating SIBO in rosacea patients may suggest that gut bacteria play a role in the pathogenesis of rosacea lesions.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)